DYRK1B and ovarian carcinoma: Mirk siRNA treatment and exposure to cisplatin in these cells resulted in increased apoptosis (measured in fold) compared with cells treated with control siRNA by caspase-3 assay (Fig. 2C), indicating that knockdown of Mirk sensitizes ovarian cancer cells to chemotherapy-induced apoptosis.